This insight was synthesized by AI from public community discussions. We do not display original user posts or comments verbatim—all content has been rewritten and aggregated. Verify before acting on it.
Evidence-Based Substance Safety Comparison Platform
A web platform that aggregates peer-reviewed safety data on psychoactive substances into standardized, comparable metrics like therapeutic index, overdose risk, and adverse effect profiles. Users currently spend significant effort manually compiling this data from scattered academic sources. The platform would serve harm reduction organizations, researchers, and individuals seeking objective safety information.
Why this matters
You are someone who wants objective, comparative safety information about psychoactive substances — perhaps for harm reduction work, academic research, or personal education. You find yourself digging through scattered academic journals, manually compiling therapeutic index tables, and debating basic safety ratios in online forums because no unified, trustworthy platform presents this data in an accessible format. When you do find information, it lacks standardized comparison metrics, and you worry about the reliability of community-sourced alternatives. You need a single, well-sourced, visually clear resource that lets you compare substances on standardized safety dimensions without spending hours on literature review.
- · Built for Harm reduction organizations, substance safety researchers, and individuals seeking objective comparative safety data on psychoactive substances.
- · Most likely monetization: Freemium with premium API access for researchers and organizations.
The Pain · Narrative
You are someone who wants objective, comparative safety information about psychoactive substances — perhaps for harm reduction work, academic research, or personal education. You find yourself digging through scattered academic journals, manually compiling therapeutic index tables, and debating basic safety ratios in online forums because no unified, trustworthy platform presents this data in an accessible format. When you do find information, it lacks standardized comparison metrics, and you worry about the reliability of community-sourced alternatives. You need a single, well-sourced, visually clear resource that lets you compare substances on standardized safety dimensions without spending hours on literature review.
Score Breakdown
Market Signal
Go-to-Market
Harm reduction organization staff and academic researchers who need standardized substance safety comparison data for educational and policy work
~30,000 harm reduction professionals globally plus ~100,000 researchers and interested individuals
Hacker News launch combined with outreach to harm reduction organizations and academic networks
$12/month for premium features, free tier with basic comparisons
500 registered users and 5 organizational inquiries within 30 days of launch
MVP Scope · 1–2 weeks
- Build core database schema for substances with fields for therapeutic index, active dose, lethal dose, and citation links
- Manually curate safety data for 15-20 most commonly discussed substances from peer-reviewed sources
- Create simple web interface with sortable comparison table of substances by safety metrics
- Implement citation display for every data point with links to source papers
- Deploy MVP to a public URL and prepare launch post
- Add interactive visualization (bar chart or radar chart) for comparing 2-3 substances side by side
- Implement search and filter functionality by substance category or safety metric
- Add community-submitted adulterant alert form with basic moderation queue
- Create an API endpoint for programmatic access to the safety database
- Launch on Hacker News and reach out to 10 harm reduction organizations for feedback
Differentiation
Why This Might Fail
Self-rebuttal — the most important trust signal
- 1Legal liability risk — even with disclaimers, providing structured substance safety data could attract regulatory attention or lawsuits if users misinterpret comparative safety data as usage endorsement.
- 2Low willingness to pay — the audience most in need of this information (individuals using unregulated substances) may have limited disposable income, while institutional buyers are a small market.
- 3Content moderation burden — community-submitted adulterant alerts require rapid verification to be useful, and unverified alerts could cause panic or false reassurance, creating a trust paradox.
Evidence Summary
How AI synthesized this insight — no verbatim quotes
Approximately 5 commenters engaged in detailed discussion of substance safety metrics, with one manually compiling a therapeutic index comparison table from an academic citation. Another commenter explicitly expressed wanting better substance accessibility for safety reasons, citing adulterant-related deaths. Multiple users debated safety ratios without easy access to standardized data, and one admitted lacking sources for their claims. This signals a genuine information gap, though commercial willingness to pay remains unproven.
Action Plan
Validate this opportunity before writing code
Recommended Next Step
Validate
Promising signals, but needs confirmation. Create a landing page, collect email sign-ups, then decide.
Landing Page Copy Kit
Ready-to-paste copy based on real Reddit community language — no editing required
Headline
Evidence-Based Substance Safety Comparison Platform
Sub-headline
A web platform that aggregates peer-reviewed safety data on psychoactive substances into standardized, comparable metrics like therapeutic index, overdose risk, and adverse effect profiles. Users currently spend significant effort manually compiling this data from scattered academic sources. The platform would serve harm reduction organizations, researchers, and individuals seeking objective safety information.
Who It's For
For Harm reduction organizations, substance safety researchers, and individuals seeking objective comparative safety data on psychoactive substances
Feature List
✓ Standardized therapeutic index comparison dashboard across substances ✓ Sourced citations from peer-reviewed literature for every data point ✓ Interactive risk visualization tools ✓ Searchable database by substance, effect, or safety metric ✓ Community-submitted adulterant alerts with geographic tagging
Where to Validate
Share your landing page in r/HN · front_page — that's exactly where these pain points were discovered.
Sign up to unlock full deep analysis
GTM, MVP scope, why-it-might-fail, ActionPlan Copy Kit. Free signup grants 10 detail views/month.
Other opportunities in the same theme
Auto-clustered by AI from related discussions